Literature DB >> 11596060

Identification and characterization of a cell surface marker for embryonic rat spinal accessory motor neurons.

W Schubert1, Z Kaprielian.   

Abstract

The developing mammalian spinal cord contains distinct populations of motor neurons that can be distinguished by their cell body positions, by the expression of specific combinations of regulatory genes, and by the paths that their axons take to exit the central nervous system (CNS). Subclasses of spinal motor neurons are also thought to express specific cell surface proteins that function as receptors which control the guidance of their axons. We identified monoclonal antibody (mAb) SAC1 in a screen aimed at generating markers for specific subsets of neurons/axons in the developing rat spinal cord. During early embryogenesis, mAb SAC1 selectively labels a small subset of Isl1-positive motor neurons located exclusively within cervical segments of the spinal cord. Strikingly, these neurons extend mAb SAC1-positive axons along a dorsally directed trajectory toward the lateral exit points. Consistent with the finding that mAb SAC1 also labels spinal accessory nerves, these observations identify mAb SAC1 as a specific marker of spinal accessory motor neurons/axons. During later stages of embryogenesis, mAb SAC1 is transiently expressed on both dorsally and ventrally projecting spinal motor neurons/axons. Interestingly, mAb SAC1 also labels the notochord and floor plate during most stages of spinal cord development. The mAb SAC1 antigen is a 100-kD glycoprotein that is likely to be the rat homolog of SC1/BEN/DM-GRASP, a homophilic adhesion molecule that mediates axon outgrowth and fasciculation. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11596060     DOI: 10.1002/cne.1356

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  9 in total

1.  Distribution of EphB receptors and ephrin-B1 in the developing vertebrate spinal cord.

Authors:  Angela R Jevince; Stephanie R Kadison; Andrew J Pittman; Chi-Bin Chien; Zaven Kaprielian
Journal:  J Comp Neurol       Date:  2006-08-10       Impact factor: 3.215

2.  Motor axon exit from the mammalian spinal cord is controlled by the homeodomain protein Nkx2.9 via Robo-Slit signaling.

Authors:  Arlene Bravo-Ambrosio; Grant Mastick; Zaven Kaprielian
Journal:  Development       Date:  2012-03-07       Impact factor: 6.868

3.  Axonal Growth of Midbrain Dopamine Neurons is Modulated by the Cell Adhesion Molecule ALCAM Through Trans-Heterophilic Interactions with L1cam, Chl1, and Semaphorins.

Authors:  Christopher R Bye; Valeria Rytova; Walaa F Alsanie; Clare L Parish; Lachlan H Thompson
Journal:  J Neurosci       Date:  2019-07-12       Impact factor: 6.167

4.  Arx together with FoxA2, regulates Shh floor plate expression.

Authors:  Ginam Cho; Youngshin Lim; Il-Taeg Cho; Jacqueline C Simonet; Jeffrey A Golden
Journal:  Dev Biol       Date:  2014-06-23       Impact factor: 3.582

5.  Mis-expression of L1 on pre-crossing spinal commissural axons disrupts pathfinding at the ventral midline.

Authors:  Ralph Imondi; Angela R Jevince; Amy W Helms; Jane E Johnson; Zaven Kaprielian
Journal:  Mol Cell Neurosci       Date:  2007-08-15       Impact factor: 4.314

6.  Transitional Nerve: A New and Original Classification of a Peripheral Nerve Supported by the Nature of the Accessory Nerve (CN XI).

Authors:  Brion Benninger; Jonathan McNeil
Journal:  Neurol Res Int       Date:  2011-01-13

Review 7.  Crossing the border: molecular control of motor axon exit.

Authors:  Arlene Bravo-Ambrosio; Zaven Kaprielian
Journal:  Int J Mol Sci       Date:  2011-11-29       Impact factor: 5.923

Review 8.  Motor neurons and the generation of spinal motor neuron diversity.

Authors:  Nicolas Stifani
Journal:  Front Cell Neurosci       Date:  2014-10-09       Impact factor: 5.505

9.  ALCAM regulates motility, invasiveness, and adherens junction formation in uveal melanoma cells.

Authors:  Karry M Jannie; Christopher S Stipp; Joshua A Weiner
Journal:  PLoS One       Date:  2012-06-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.